| • Clarke Inquiry (2)
• New professional body
• The Society (2)
• Community pharmacy (2)
• Pharmacy practice
• Technicians
• The industry
• WCPPE
• Drug addiction
• Research
Letters to the Editor
|
Pharmacy practice
Patients should know the cost of their medicines
From Mr M. M. Furnell, MRPharmS
I recently surveyed pharmacy practice in other countries. Patients who
are eligible to receive free or discounted medicines or who pay the full
cost of their prescriptions are actively given details of the cost of
their dispensed medicines in South Australia, in Ontario, Canada, and
in some European countries.
In South Australia this system has been in place for approximately three
years. My contact suggested that this practice has made some patients
more accepting if their pharmacy did not stock a high cost item and they
had to give a day’s notice to obtain it for them.
Similarly, in
Ontario, all patients are given an official prescription receipt, breaking
down exactly what costs the patient or their drug plan are paying, even
for patients who receive free treatment. In parts of Europe the drug
cost is printed on the manufacturer’s container label.
From recent personal experience, a patient who had brought his specialist
injection with him into hospital but later left hospital without taking
it home was surprised when I informed him that it costs £1,200
per dose and as it was his own from home we could not use it for anyone
else; he soon returned to the hospital to retrieve it from the ward.
The research referred to in the “Prescribing costs in primary care” report
from the House of Commons Public Accounts Committee (January 2008) was
inconclusive about whether putting the medicine price on the box was
helpful to patients. Comment from a senior Department of Health representative
stated that they will be undertaking further research on the topic in
terms of medicines waste.
In these days of transparency, I believe that patients have the right
to know how much their drugs cost, and may even be interested to know
this information. With the coming of the electronic prescription service
it should be possible to print the cost of a dispensed medicine downloaded
direct from the pricing bureau at the same time as the dispensed prescription
is sent electronically to the pricing bureau.
Now may be the time to
start the process rolling for this to be included in the software. That
way the pharmacist can show the NHS price of the drug without having
to disclose any confidential local contract prices and without having
to take into account any on-cost allowances payable to the contractor.
Further research will show whether making the cost of a dispensed drug
available to patients will affect medicines waste or change medication
compliance. Is there information from the recent Australian initiative
that can be shared? I think that the Royal Pharmaceutical Society should
reconsider the report’s proposal and encourage the research.
Malcolm Furnell
Brighton |